Crinetics Pharmaceuticals (CRNX) Liabilities and Shareholders Equity (2017 - 2026)
Crinetics Pharmaceuticals' Liabilities and Shareholders Equity came in at $1.32 billion for Q2 2026, up 2.5% from $1.29 billion a year earlier but down 5.7% from the prior quarter.
Crinetics Pharmaceuticals (CRNX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Crinetics Pharmaceuticals' Liabilities and Shareholders Equity was $1.13 billion, down 21.5% from FY2024.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 43.8% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $1.43 billion in FY2024 (+125.8%), $635.35 million in FY2023 (+80.4%), $352.18 million in FY2022 (+0.3%) and $351.02 million in FY2021 (+91.3%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $209.36 million (Q3 2021) to $1.43 billion (Q4 2024).
- Year-over-year, Liabilities and Shareholders Equity increased in seven of the last eight quarters, with growth averaging 32.6%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2024 (growth of 219.0%), and the weakest in Q2 2023 (a decline of 30.5%).
- Business Quant data shows CRNX's Liabilities and Shareholders Equity at $1.4 billion (Q1 2026), $1.13 billion (Q4 2025) and $1.2 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 1.32 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Bn |
| Mar 31, 2026 | 1.40 Bn |
| Dec 31, 2025 | 1.13 Bn |
| Sep 30, 2025 | 1.20 Bn |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 937.37 Mn |
| Jun 30, 2024 | 935.54 Mn |
| Mar 31, 2024 | 978.15 Mn |
| Dec 31, 2023 | 635.35 Mn |
| Sep 30, 2023 | 641.54 Mn |
| Jun 30, 2023 | 293.25 Mn |
| Mar 31, 2023 | 314.01 Mn |
| Dec 31, 2022 | 352.18 Mn |
| Sep 30, 2022 | 384.88 Mn |
| Jun 30, 2022 | 421.73 Mn |
| Mar 31, 2022 | 333.29 Mn |
| Dec 31, 2021 | 351.02 Mn |
| Sep 30, 2021 | 209.36 Mn |
Crinetics Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRNX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();